
Professor Jean-Francois Korobelnik, University Hospital of Bordeaux, France
Advertisement
Articles by Professor Jean-Francois Korobelnik, University Hospital of Bordeaux, France

Advertisement
Latest Updated Articles
EYLEA’s unique MoA: What is the rationale for the higher molar dose?Published: January 23rd 2025 | Updated:
Advertisement
Advertisement
Trending on Modern Retina
1
EyePoint receives second consecutive positive recommendation from DSMC
2
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
3
Corza Medical announces launch of the SensorTek ROP Kit
4
FLORetina Congress celebrates 10 years with joint World Retinopathy of Prematurity meeting
5
